These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4736912)

  • 1. Schedule dependence of the lethal effects of 6-azauridine and cytosine arabinoside on murine leukemia cels (L5178Y) in culture.
    Brenckman WD; Chu MY; Fischer GA
    Biochem Biophys Res Commun; 1973 Jun; 52(4):1368-73. PubMed ID: 4736912
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of cytosine arabinoside, adenine arabinoside, and 6-azauridine on rabies virus in vitro and in vivo.
    Harmon MW; Janis B
    J Infect Dis; 1976 Jan; 133(1):7-13. PubMed ID: 1245759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy with cytosine arabinoside, L-asparaginase, and 6-azauridine for transplantable murine leukemias.
    Avery TL; Roberts D
    Cancer Res; 1973 Apr; 33(4):791-9. PubMed ID: 4696479
    [No Abstract]   [Full Text] [Related]  

  • 4. [(IgG)2 protein A]2 complex stimulates cytosine arabinoside incorporation into DNA and inhibits L cell proliferation.
    Shearer WT; Green CG; Gilliam EB; Langone JJ
    Immunopharmacology; 1984 Oct; 8(2):103-10. PubMed ID: 6511365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect and toxicity of combination treatment including cyclocytidine or cytosine arabinoside in L-1210 and sarcoma-180 systems.
    Hoshi A; Kanzawa F; Iigo M; Kuretani K
    Gan; 1975 Oct; 66(5):539-46. PubMed ID: 1220992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on a new mechanism of resistance of L5178Y murine leukemia cells to cytosine arabinoside.
    Momparler RL; Chu MY; Fischer GA
    Biochim Biophys Acta; 1968 Jul; 161(2):481-93. PubMed ID: 4174433
    [No Abstract]   [Full Text] [Related]  

  • 7. Concurrent development of resistance to 6-azauridine and adenosine in a mouse cell line.
    Hashmi S; May SR; Krooth RS; Miller OJ
    J Cell Physiol; 1975 Oct; 86(2 Pt 1):191-200. PubMed ID: 1194360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective chemotherapy for advanced murine L 1210 leukemia by combination of 2' deoxycytidine and lethal doses of cytosine-arabinoside.
    Buchman VM; Svet-Maoldavsky GJ; Lichinitser MR; Mkheidze DM
    Biomedicine; 1977 Jul; 27(5):179-80. PubMed ID: 922116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cytosine arabinoside on the replication of the Moloney sarcoma virus in 3T3 cell cultures.
    Hirschman SZ; Fischinger PJ; Zaccari JJ; O'Connor TE
    J Natl Cancer Inst; 1969 Mar; 42(3):399-411. PubMed ID: 5777489
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of acronycine, bleomycin and cytosine arabinoside on the cell cycle. Some aspects of their interaction with radiation determined by pulse cytophotometry.
    Reddy SB; Linden WA; Zywietz F; Baisch H; Struck U
    Arzneimittelforschung; 1977; 27(8):1549-53. PubMed ID: 71899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential cell-cycle-dependent inhibition of DNA synthesis by hydroxyurea and cytosine arabinoside in cultured L5178Y mouse lymphoma cells.
    Malec J; Kornacka L; Sawecka J
    Arch Immunol Ther Exp (Warsz); 1979; 27(4):539-45. PubMed ID: 518260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of the antiproliferative action of 1- -D-arabinofuranosylcytosine by methotrexate in murine leukemic cells (L5178Y).
    Hoovis ML; Chu MY
    Cancer Res; 1973 Mar; 33(3):521-5. PubMed ID: 4734734
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased accumulation of cytosine arabinoside in human leukemic cells and enhancement of its cell-killing activity by uridine.
    Takahashi I; Hayashi N; Nakamura T; Matuzaki T; Murase T; Osada K; Takeuchi M; Ueki Y; Nakada H; Yorimitsu S
    Acta Med Okayama; 1990 Dec; 44(6):329-31. PubMed ID: 2075831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cell-cycle information in the preparation of drug combinations: results with cytosine arabinoside plus actinomycin D1,2.
    Bhuyan BK; Fraser TJ; Day KJ
    Cancer Treat Rep; 1976 Dec; 60(12):1813-8. PubMed ID: 1036090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of continuous infusion of cytosine arabinoside on sequencing with daunorubicin in L1210 leukemia.
    Edelstein M; Valeriote F; Vietti T
    Cancer Treat Rep; 1978 Apr; 62(4):547-8. PubMed ID: 657151
    [No Abstract]   [Full Text] [Related]  

  • 16. Sensitivity of human leukemic cells to anti-cancer agents in culture.
    Chu MY; Hoovis ML
    Biochem Pharmacol; 1974 Feb; 23(3):503-11. PubMed ID: 4274612
    [No Abstract]   [Full Text] [Related]  

  • 17. Decrease of serum pyridoxal phosphate levels and homocystinemia after administration of 6-azauridine triacetate and their prevention by administration of pyridoxine.
    Slavik M; Smith KJ; Blanc O
    Biochem Pharmacol; 1982 Dec; 31(24):4089-92. PubMed ID: 6186258
    [No Abstract]   [Full Text] [Related]  

  • 18. Protection of intestinal damage by pretreatment with cytarabine (cytosine arabinoside).
    Phelps TA; Blackett NM
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1617-20. PubMed ID: 536270
    [No Abstract]   [Full Text] [Related]  

  • 19. Synergistic effect of combined intraperitoneal cisplatin and cytosine arabinoside in a murine ovarian cancer model.
    Berek JS; Schink JC; Knox RM
    Obstet Gynecol; 1989 Oct; 74(4):663-6. PubMed ID: 2797645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular pharmacodynamic studies of the synergistic combination of 6-mercaptopurine and cytosine arabinoside in human leukemia cell lines.
    Ramilo-Torno LV; Avramis VI
    Cancer Chemother Pharmacol; 1995; 35(3):191-9. PubMed ID: 7805176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.